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ABSTRACT
Objectives: Development of antimicrobial resistance in microorganism isolated from blood stream infection constitutes a major concern about their 
treatment. Teicoplanin is a glycopeptide antibiotic used in the treatment of infection caused by Gram-positive bacteria. This study was planned to 
determine Teicoplanin resistance in the Central India and recommend policy changes for prevention of the future resistance to the higher antibiotics.
Methods: A total of 1855 septicemia suspected blood samples were studied. The blood culture samples were processed and identified in the 
microbiology laboratory according to the Clinical and Laboratory Standards Institute guidelines. Antibiotic susceptibility test was done using Kirby 
B disk diffusion method.
Results: About 39.5% of blood culture samples showed positive growth for organism. We observed high teicoplanin resistance (29.5%) among Gram-
positive isolates, predominantly (53%) in the Enterococcus species.
Conclusion: Teicoplanin resistance has emerged tremendously in the present study. Hence, attention is required about this serious issue otherwise 
very limited choice of antibiotics will be available for treating infections in the future.
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INTRODUCTION
Teicoplanin is a glycopeptide antimicrobial agent which has almost 
similar antimicrobial spectrum as Vancomycin. It is active against 
infections caused by Coagulase Negative Staphylococcus (CONS), 
various Enterococcus species, Methicillin-Resistant Staphylococcus 
Aureus, and in some cases Vancomycin Resistance Staphylococci [1]. 
It is a bactericidal agent against susceptible Gram-positive bacterial 
strains and may be effective in Clostridium difficile-associated diarrhea 
and pseudomembraneous colitis.
Teicoplanin binds with the D-Alanyl-D-alanine terminals of cell 
wall precursor units and thus inhibits bacterial cell wall synthesis. 
Teicoplanin does not penetrate the outer membranes of Gram-negative 
bacteria because of their large molecular size [2]. The Minimum 
Inhibitory Concentration (MIC) of teicoplanin for Staphylococcus, 
Streptococcus pneumonia, viridians/non-viridians streptococci and 
Enterococci is 0.01–1 μg/ml whereas the MIC for Corynebacterium 
species, anaerobic Gram-positive cocci, and Listeria species is 0.25-2 
μg/ml [3]. Teicoplanin has a fused ring structure contain a mixture of 
five major (A2-1–A2-5), four minor (RS-1–RS-4), and two carbohydrates 
(mannose and N-acetylglucosmine) compounds. Major and minor 
components contain a third carbohydrate moiety-Beta-D-glucosamine, 
all share same core of glycopeptides termed as teicoplanin A3-1 [4]. 
Antibacterial activity of Teicoplanin is affected by its protein binding 
capacity, it is highly bound by plasma proteins (90–95%). Teicoplanin 
has a long serum elimination half-life, (up to 100 h) with normal renal 
function in adult patients [5].
Vancomycin and Teicoplanin both have different antimicrobial activity, 
lipophilic activity, and pharmacokinetic properties with almost similar 
structures. Teicoplanin binds as a monomer whereas Vancomycin 
forms a dimer. Teicoplanin antibiotic susceptibility testing for CONS can 
be problematic because of poor diffusion of the molecule in solid media 
and effect of the medium used [6]. Glycopeptides intermediate S. aureus 
(GISA) isolates MIC range (4–16 μg/ml) have been recovered from 
patients after prolonged glycopeptides exposure in the recent years 
from most parts of the world. Glycopeptides resistance intrinsically 
arises due to frequent exposure, multiple mutations, and/or alterations 
in gene expression [7].
The purpose of our study was to determine the Teicoplanin-resistant 
among isolates from bacteremia or septicemia in the Central India and 
recommend strategy for the prevention of Teicoplanin resistance in the 
future.
METHODS
A cross-sectional observational study was conducted on 1855 blood 
culture isolates at Gandhi Medical College and associated Hamidiya 
Hospital, Bhopal, Madhya Pradesh, India, a 1000 bedded tertiary care 
hospital in the Central India.
All the blood samples were withdrawn and collected using strict aseptic 
measures and sent for culture and sensitivity testing to the clinical 
bacteriology laboratory. Blood culture was done by conventional 
blood culture method (BHI broth). Thereafter, bacterial isolates 
identification was performed from colony morphology, gram staining, 
and biochemical tests.
Teicoplanin sensitivity testing was performed by Kirby-Bauer’s disk 
diffusion method using Mueller Hinton agar plates as per Clinical 
and Laboratory Standards Institute guidelines [8]. Inoculums of 0.5 
McFarland standards were poured on Mueller-Hinton Agar plates and 
a 30 μg Teicoplanin disk was applied. All plates were incubated for 16–
20 h at 35–37°C temperature. A zone size more than 15 mm was taken 
as susceptible and <15 mm as resistance.
© 2021 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons.org/
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Data analysis
The proportion and percentage, confidence interval of the resistant 
isolates was calculated using graph pad software. The confidence 
intervals below are calculated using the so-called “exact” confidence 
intervals, computed by the method of Clopper and Pearson which are 
based on a relationship between the F distribution and the binomial 
distribution.
Ethical consideration
The study was approved by Institutional Ethical Committee of Gandhi 
Medical College and associated Hamidiya hospital, Barakattullah 
University Bhopal M.P. Ethical guidelines given by the Declaration of 
Helsinki were adhered to throughout the study.
RESULTS
Table 1 shows geographical distribution of blood culture cases. Total 
of 1855 blood samples were received from different wards including 
medicine, pediatric, surgery, and burn. The maximum number 
of samples was received from pediatric wards followed by other 
department such as medicine, surgery, orthopedic, and burn. Out of 
1855 blood sample received, 732 turn out to be positive for growth of 
bacteria (Table 2). The positive rate was found to be 39.4%.
Frequency of total blood isolates (Table 3 and Figure 1)
Of 732 positive culture Gram-negative strain accounts for 610 (83.33%), 
whereas Gram-positive strain was found to be 122 (16.66%). The 
isolated Gram-negative isolates include Klebsiella 317 (43.3%), E. Coli 
121 (16.5%), Pseudomonas 76 (10.3%), the non-lactose fermenting 
Gram-negative bacteria 54 (7.3%), Citrobacter 36 (4.9%), and 
Acinatobacter 6 (0.8%). The Gram-positive bacteria isolated includes S. 
aureus 87 (11.8%), CONS 20 (2.7%), and Enterococcus 15 (2%).
Resistance to teicoplanin (Table 4)
The resistance to Teicoplanin among different Gram-positive bacterial 
isolates was found to be in staphylococcus 20 (23%), CONS 8 (40%), 
and Enterococcus 8 (53%).
DISCUSSION
Our study showed that 732 (39.4%) out of 1855 total samples were 
positive for presence of bacteria which is almost similar to Khanal 
et al. [9] and Sharma et al. [10], who reported positive blood cultures 
accounting for 44–33.9%, respectively but some other studies showed 
lower prevalence like Mehdinejad et al. [11], Vanitha et al. [12]., Kalpesh 
Gohel et al. [13], and Mehta et al. [14] reported 5.6%, 8.3%, 9.2%, and 
9.9%, respectively. Higher prevalence rate (39.4%) in our study may be 
due to emerging of multidrug-resistant bacterial strains and inadequate 
or rational use of antibiotic. Probable reasons for variation in blood 
culture positivity rate are amount of blood taken, administration 
of antibiotic therapy before blood collection, nature of population, 
epidemiological difference of the etiological agents, and different areas 
of study. Gram-negative bacteria were tremendous (83.3%) in the 
present study which was similar to Vaghela et al. [15], Paul et al. [16], 
and Santwana Pandey et al. [17]. However, this contrasts with other 
studies where Gram-positive organisms were predominant like Belay 
et al. [18], Muley et al. [19], Pan et al. [20], and Sorsa et al. [21]. This 
variation of blood culture isolates may be due to various factors such as 
geographical location, seasonal variation, and endemicity of etiological 
agents.
In our study, we observed high prevalence of Teicoplanin resistance 
in CONS strain 40% which was concordance to Bertin et al. [22] and 
Lallemand [23] but in discordance to our study many other observers 
showed very low prevalence to Teicoplanin resistance like Schlegel 
et al. [24] and Julie et al. [25].
Teicoplanin resistance in S. aureus strain was 23% reported in the 
present study in contrary to that other authors like Szymanek-
Majchrzak et al. [26] and Shuchi Kaushik et al. [27] showed very high 
resistance 76.6% and 66%, respectively. Nidhi Pal et al. [28] and Vanitha 
Table 4: Resistance pattern to Teicoplanin
Bacteria No. of resistant 
isolates




Staphylococcus 20 (n=87) 23 0.1464–0.3325
CONS 8 (n=20) 40 0.1912–0.6395
Enterococcus 8 (n=15) 53 0.2659–0.7873
Total 36 (n=122) 29.5 0.2180–0.3844
Table 2: Age-wise distribution of blood culture samples 
(n=1855)
Age Growth No growth Total
Infant (<1 year) 226 338 564
Children (1–12) 165 242 407
Adolescent (13–18) 102 157 259
Adult (18–49) 111 188 299
Old (>50 years) 128 198 326
Total 732 1123 1855
Table 3: Frequency of bacterial isolates obtained from blood 
sample (n=732)
S. No Bacteria isolated Number Percentage Confidence 
Interval
1 Klebsiella 317 43.3 0.3968–0.4698
2 E. coli 121 16.5 0.1391–0.1942
3 Pseudomonas 76 10.3 0.0827–0.0952
4 NLFGNB 54 7.3 0.0559–0.0952
5 NLFGNB 36 4.9 0.0347–0.0674
6 Acinabactor 6 0.8 0.0030–0.0178
7 Staphylococcus 87 11.8 0.0963–0.1445
8 CONS 20 2.75 0.0168–0.0419
9 Enterococcus 15 2 0.0115–0.0336
Table 1: Districts-wise distribution of positive and total blood 
culture cases
District Positive cases (%) Total cases
Bhopal 415 (40.5) 1025
Raisen 102 (35.6) 286
Vidisha 74 (37.4) 198
Sehore 86 (40.3) 213
Rajgarh 37 (43.5) 85
Hoshangabad 18 (37.5) 48




























Figure 1: Growth profile of the blood culture samples
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et al. [12] observed very low Teicoplanin resistance. The present study 
found that Enterococcus were highly resistance to Teicoplanin 53% in 
discordance to that Palewar et al. [29] and Gupta et al. [30] reported 
very low resistance to Teicoplanin.
In the present study, we were reported 39.5% Teicoplanin resistance in 
overall Gram-positive isolates in the Central India which was clinically 
and statically significant in because the majority of the previous studies 
in the Central India like Koksal et al. [31], Tripathi et al. [32], and Sodani 
et al. [33] reported 100% susceptibility to Teicoplanin
The increasing Teicoplanin resistance in the present study could be 
due to unregulated or widespread use of the drug in the empirical 
treatment protocol, altered virulence factor expression, and altered 
autolytic properties of the resistant organism.
CONCLUSION
Teicoplanin is a reserve antibiotic for multi-drug-resistant staphylococci 
or Enterococci and therefore emergence of Teicoplanin resistance is a 
serious concern. This mandates judicious use of antimicrobials and a 
strict antibiotic policy on a large scale to decrease or prevents further 
Teicoplanin resistance.
RECOMMENDATIONS
Recommendation of policy changes in the future for prevention of 
antibiotics resistance are as under:
•	 Health-care professionals should be educated about antibiotics 
resistance and its consequences
•	 Antibiotics should be used judiciously
•	 Appropriate antibiotics should be used only after culture-sensitivity 
reports
•	 Control of substandard and counterfeit uses of antimicrobials
•	 All health-care facilities should have an antibiotic monitoring 
committee, a strict antibiotic policy which is updated periodically
•	 All health-care facilities should maintain detailed records regarding 
antibiotics use and resistance patterns.
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